Drug Profile
Fluticasone propionate - DMK Pharmaceuticals
Alternative Names: APC 4000Latest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Adamis Pharmaceuticals Corporation
- Developer DMK Pharmaceuticals
- Class Analgesics; Androstadienes; Anti-inflammatories; Antiallergics; Antiasthmatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Inorganic sulfur compounds; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 07 Sep 2023 Adamis Pharmaceuticals Corporation is now called DMK Pharmaceuticals
- 15 Apr 2021 Discontinued - Phase-II for Asthma in USA (Inhalation) (Adamis Pharmaceuticals SEC filing, April 2021 )
- 15 Apr 2021 Discontinued - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation) (Adamis Pharmaceuticals SEC filing, April 2021 )